[go: up one dir, main page]

NO953767L - Tverrbundet amylose som et binde-/opplösende middel i tabletter - Google Patents

Tverrbundet amylose som et binde-/opplösende middel i tabletter

Info

Publication number
NO953767L
NO953767L NO953767A NO953767A NO953767L NO 953767 L NO953767 L NO 953767L NO 953767 A NO953767 A NO 953767A NO 953767 A NO953767 A NO 953767A NO 953767 L NO953767 L NO 953767L
Authority
NO
Norway
Prior art keywords
binder
dissolving agent
tablets
crosslinked amylose
amylose
Prior art date
Application number
NO953767A
Other languages
English (en)
Other versions
NO953767D0 (no
Inventor
Louis Cartilier
Yves Dumoulin
Mircea A Mateescu
Vincent Lenaerts
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Publication of NO953767L publication Critical patent/NO953767L/no
Publication of NO953767D0 publication Critical patent/NO953767D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Den foreliggende oppfinnelse angår fremstilling av faststoff doseenheter (farmasøytiske og andre). Mer spesifikt angår oppfinnelsen pulver av tverr- bundet amylose som har en spesifikk tverr- bindingsgrad for anvendelse som tablettbindemiddel og tablettoppløsende middel.
NO953767A 1993-03-25 1995-09-22 Tverrbundet amylose som et binde-/opplösende middel i tabletter NO953767D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/037,119 US5616343A (en) 1993-03-25 1993-03-25 Cross-linked amylose as a binder/disintegrant in tablets
PCT/CA1994/000163 WO1994021236A1 (en) 1993-03-25 1994-03-22 Cross-linked amylose as a binder/disintegrant in tablets

Publications (2)

Publication Number Publication Date
NO953767L true NO953767L (no) 1995-09-22
NO953767D0 NO953767D0 (no) 1995-09-22

Family

ID=21892532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953767A NO953767D0 (no) 1993-03-25 1995-09-22 Tverrbundet amylose som et binde-/opplösende middel i tabletter

Country Status (17)

Country Link
US (1) US5616343A (no)
EP (1) EP0689429B1 (no)
JP (1) JP2831851B2 (no)
CN (1) CN1119828A (no)
AT (1) ATE141046T1 (no)
AU (1) AU679732B2 (no)
CA (1) CA2155210A1 (no)
CZ (1) CZ285201B6 (no)
DE (1) DE69400356T2 (no)
ES (1) ES2091142T3 (no)
FI (1) FI954232A7 (no)
GR (1) GR3021433T3 (no)
HU (1) HUT73667A (no)
NO (1) NO953767D0 (no)
NZ (1) NZ262876A (no)
PL (1) PL310815A1 (no)
WO (1) WO1994021236A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
DE19640062B4 (de) 1996-09-28 2006-04-27 Lts Lohmann Therapie-Systeme Ag Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
AU7501398A (en) * 1997-05-21 1998-12-11 Warner-Lambert Company Non-sedating acrivastine preparation
CA2217238C (en) * 1997-10-24 2005-09-20 Louis Cartilier Cross-linked cellulose as a tablet excipient
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
BR0016482A (pt) 1999-12-06 2002-12-24 Mendell Co Inc Edward Método para melhorar a compressibilidade de um superdesintegrante, obter um complexo de preparado de droga superdesintegrante altamente compatìvel , superdesintegrante aumentado e sua forma de dosagem sólida
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US6846497B2 (en) 2003-01-30 2005-01-25 National Starch And Chemical Investment Holding Corporation Rapidly expanding starches with altered crystalline structure
WO2005018678A1 (ja) * 2003-08-26 2005-03-03 Ezaki Glico Co., Ltd. 錠剤用添加剤
NO319624B1 (no) * 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US8871270B2 (en) * 2004-07-09 2014-10-28 Corn Products Development, Inc Tablet excipient
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
EP1717215A1 (fr) * 2005-04-19 2006-11-02 Lafarge Procédé de compaction de liant hydraulique et compacts broyés
CN101252932B (zh) * 2005-09-09 2012-10-03 安吉利尼莱博法姆有限责任公司 用于一天给药一次的曲唑酮组合物
RU2008113439A (ru) * 2005-09-09 2009-10-20 Лабофарм Инк. (CA) Композиции с замедленным высвобождением лекарственного средства
EP2203166B1 (en) * 2007-10-16 2015-05-06 Paladin Labs Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
EP2219612A4 (en) * 2007-12-17 2013-10-30 Paladin Labs Inc FORMULATION WITH TAXED RELEASE AND ABUSE PROTECTION
EP2261263B1 (en) 2008-03-31 2022-03-23 Asahi Kasei Kabushiki Kaisha Processed starch powder with excellent disintegration properties and manufacturing method thereof
CA2746888C (en) 2008-12-16 2015-05-12 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
AU2011276170B2 (en) 2010-07-06 2016-03-10 Grunenthal Gmbh Novel gastro- retentive dosage forms comprising a GABA Analog and an opioid
WO2012007159A2 (en) 2010-07-14 2012-01-19 Grünenthal GmbH Novel gastro-retentive dosage forms
CN108456050A (zh) * 2018-01-24 2018-08-28 天津水泥工业设计研究院有限公司 一种低成本的生产圆颗粒矿物肥料的造粒添加剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4072535A (en) * 1970-12-28 1978-02-07 A. E. Staley Manufacturing Company Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US4088798A (en) * 1975-11-11 1978-05-09 Sandoz, Inc. Methods for the preparation of controlled gastric residence time medicament formulations
US4230687A (en) * 1978-05-30 1980-10-28 Griffith Laboratories U.S.A., Inc. Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
US4369308A (en) * 1981-07-24 1983-01-18 National Starch And Chemical Corporation Low swelling starches as tablet disintegrants
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4933185A (en) * 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US4755397A (en) * 1986-12-24 1988-07-05 National Starch And Chemical Corporation Starch based particulate encapsulation process
US4812445A (en) * 1987-02-06 1989-03-14 National Starch And Chemical Corporation Starch based encapsulation process
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
CA2032385A1 (en) * 1990-12-17 1992-06-18 Chung Wai-Chiu Enzymatically debranched starches as tablet excipients

Also Published As

Publication number Publication date
EP0689429B1 (en) 1996-08-07
WO1994021236A1 (en) 1994-09-29
US5616343A (en) 1997-04-01
CZ285201B6 (cs) 1999-06-16
NZ262876A (en) 1997-01-29
GR3021433T3 (en) 1997-01-31
JP2831851B2 (ja) 1998-12-02
HUT73667A (en) 1996-09-30
EP0689429A1 (en) 1996-01-03
CN1119828A (zh) 1996-04-03
ES2091142T3 (es) 1996-10-16
ATE141046T1 (de) 1996-08-15
NO953767D0 (no) 1995-09-22
CZ248695A3 (en) 1996-01-17
AU679732B2 (en) 1997-07-10
CA2155210A1 (en) 1994-09-29
PL310815A1 (en) 1996-01-08
FI954232L (fi) 1995-09-08
HU9502790D0 (en) 1995-11-28
FI954232A0 (fi) 1995-09-08
DE69400356T2 (de) 1996-11-28
FI954232A7 (fi) 1995-09-08
JPH08507769A (ja) 1996-08-20
DE69400356D1 (de) 1996-09-12
AU6279994A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
NO953767L (no) Tverrbundet amylose som et binde-/opplösende middel i tabletter
NO20004208L (no) Fornettet stivelse med høyt amyloseinnhold og med funksjonelle grupper som en matriks for frigivning av farmasøytiske midler
NO304374B1 (no) 1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, og farmas°ytiske blandinger som inneholder dem
FI962487A0 (fi) Rapamysiinijohdannaisia
BR9509019B1 (pt) comprimido isento de solventes orgÂnicos.
ATE177630T1 (de) Gegen missbrauch geschuetzte tabletten
DK0717617T3 (da) Mikropartikler indeholdende aktive bestanddele og gas
DK1239857T3 (da) Dual-release-præparater af en cyclooxygenase-2-hæmmer
HUP0102206A2 (hu) Delavirdint tartalmazó tabletta formájú készítmény
ATE224360T1 (de) Adamantan-derivate
NO983812D0 (no) Nye assosiasjoner av aktive prinsipper inneholdende clopidogrel og et antitrombotisk middel
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
GB2251502B (en) Data-loss prevention products
ATE258788T1 (de) Tablette
ATE187640T1 (de) Arzneimittel in tablettenform mit verzögerter wirkstoffabgabe auf basis von hochmolekularen polysaccharidgranulaten
CZ15295A3 (en) Solid pharmaceutical dosing unit
FI963567A0 (fi) Diklofenakki-Na:a sisältävä depottabletti
NO921906D0 (no) Nye 2-amino-5-cyano-1,4-dihydropyridiner, deres fremstilling og anvendelse i legemidler
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
FI952765A0 (fi) Desogestreeliä sisältävä tabletti, kapseli tai rae